Avanos Medical Inc (AVNS) - Total Assets
Based on the latest financial reports, Avanos Medical Inc (AVNS) holds total assets worth $1.05 Billion USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Avanos Medical Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Avanos Medical Inc - Total Assets Trend (2011–2025)
This chart illustrates how Avanos Medical Inc's total assets have evolved over time, based on quarterly financial data. See AVNS net asset value for net asset value and shareholders' equity analysis.
Avanos Medical Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Avanos Medical Inc's total assets of $1.05 Billion consist of 33.1% current assets and 66.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 8.4% |
| Accounts Receivable | $103.80 Million | 9.7% |
| Inventory | $148.00 Million | 13.8% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $117.80 Million | 11.0% |
| Goodwill | $394.90 Million | 36.8% |
Asset Composition Trend (2011–2025)
This chart illustrates how Avanos Medical Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Avanos Medical Inc (AVNS) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Avanos Medical Inc's current assets represent 33.1% of total assets in 2025, an increase from 0.0% in 2011.
- Cash Position: Cash and equivalents constituted 8.4% of total assets in 2025, up from 0.0% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 46.0% of total assets, an increase from 0.0% in 2011.
- Asset Diversification: The largest asset category is goodwill at 36.8% of total assets.
Avanos Medical Inc Competitors by Total Assets
Key competitors of Avanos Medical Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
COCHLEAR LTD ADR 1/2/O.N.
F:OC50
|
Germany | €2.83 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351
|
China | CN¥2.00 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
Vitrolife AB
ST:VITR
|
Sweden | Skr11.24 Billion |
|
HOB Biotech Group Corp Ltd
SHG:688656
|
China | CN¥912.83 Million |
|
Imricor Medical Systems Inc
AU:IMR
|
Australia | AU$45.79 Million |
Avanos Medical Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.48 | 2.57 | 2.80 |
| Quick Ratio | 1.40 | 1.56 | 1.79 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $193.80 Million | $215.20 Million | $285.20 Million |
Avanos Medical Inc - Advanced Valuation Insights
This section examines the relationship between Avanos Medical Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.48 |
| Latest Market Cap to Assets Ratio | 1.08 |
| Asset Growth Rate (YoY) | -7.0% |
| Total Assets | $1.07 Billion |
| Market Capitalization | $1.16 Billion USD |
Valuation Analysis
Above Book Valuation: The market values Avanos Medical Inc's assets above their book value (1.08x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: Avanos Medical Inc's assets decreased by 7.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Avanos Medical Inc (2011–2025)
The table below shows the annual total assets of Avanos Medical Inc from 2011 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $1.07 Billion | -6.97% |
| 2024-12-31 | $1.15 Billion | -31.80% |
| 2023-12-31 | $1.69 Billion | -5.29% |
| 2022-12-31 | $1.79 Billion | +11.43% |
| 2021-12-31 | $1.60 Billion | -4.14% |
| 2020-12-31 | $1.67 Billion | -7.05% |
| 2019-12-31 | $1.80 Billion | -1.84% |
| 2018-12-31 | $1.83 Billion | -16.51% |
| 2017-12-31 | $2.20 Billion | +5.99% |
| 2016-12-31 | $2.07 Billion | +3.58% |
| 2015-12-31 | $2.00 Billion | -20.87% |
| 2014-12-31 | $2.53 Billion | +1.76% |
| 2013-12-31 | $2.48 Billion | -1.98% |
| 2012-12-31 | $2.53 Billion | -- |
| 2011-12-31 | $0.00 | -- |
About Avanos Medical Inc
Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including… Read more